Marketing-authorisation holder · Canada
Ferring Inc
60 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
60 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 60
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADSTILADRIN300000000000 vp / ml · Suspension | Nadofaragene firadenovec | Canada | Authorised | |
| CERVIDIL10 mg / insert · Insert | Dinoprostone | Canada | Marketed | 1997 |
| CORTIMENT9 mg · Tablet (Delayed- And Extended-Release) | Budesonide | Canada | Marketed | 2016 |
| DDAVP INJ 4MCG/ML4 mcg / ml · Liquid | Desmopressin | Canada | Marketed | 1993 |
| DDAVP MELT120 mcg · Tablet (Orally-Disintegrating) | Desmopressin | Canada | Marketed | 2006 |
| DDAVP MELT60 mcg · Tablet (Orally-Disintegrating) | Desmopressin | Canada | Marketed | 2006 |
| DECAPEPTYL0.1 mg / ml · Solution | Triptorelin | Canada | Marketed | 2012 |
| DURATOCIN100 mcg / ml · Solution | Carbetocin | Canada | Marketed | 2020 |
| ENDOMETRIN100 mg · Vaginal Tablet (Effervescent) | Progesterone | Canada | Marketed | 2009 |
| FIRMAGON120 mg / vial · Powder For Solution | Degarelix | Canada | Marketed | 2009 |
| FIRMAGON80 mg / vial · Powder For Solution | Degarelix | Canada | Marketed | 2009 |
| LUTREPULSE3.2 mg / vial · Powder For Solution | Gonadorelin | Canada | Not marketed | 1994 |
| MENOPUR75 unit / vial · Powder For Solution | Human menopausal gonadotropin | Canada | Marketed | 2006 |
| OCTOSTIM LIQ INJ. 15MCG/ML15 mcg / ml · Solution | Desmopressin | Canada | Marketed | 1995 |
| PENTASA500 mg · Tablet (Extended-Release) | Mesalazine | Canada | Marketed | 1994 |
| PENTASA1 G · Suppository | Mesalazine | Canada | Marketed | 1995 |
| PENTASA4 g / 100 ml · Suspension | Mesalazine | Canada | Marketed | 1995 |
| PENTASA1 g / 100 ml · Suspension | Mesalazine | Canada | Marketed | 1995 |
| PENTASA1 G · Tablet (Extended-Release) | Mesalazine | Canada | Marketed | 2013 |
| PICO-SALAX12 g / sachet + 3.5 g / sachet + 10 mg / sachet · Powder For Solution | Citric acid, Magnesium oxide, Picosulfate | Canada | Marketed | 2004 |
| REBYOTA50000000000 cfu / ml · Suspension | Fecal microbiota | Canada | Marketed | 2025 |
| REKOVELLE72 mcg / 2.16 ml · Solution | Follitropin delta | Canada | Marketed | 2019 |
| REKOVELLE12 mcg / 0.36 ml · Solution | Follitropin delta | Canada | Marketed | 2019 |
| REKOVELLE36 mcg / 1.08 ml · Solution | Follitropin delta | Canada | Marketed | 2019 |
| BISACODYL 5MG5 mg · Tablet | Bisacodyl | Canada | Cancelled | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 60 | 24 | 36 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.